TCBP

0.3661

3.40% -0.0129

Vorhandelsmarkt: .37 0.0039 +1.07%

Tc Biopharm Holdings Plc Adr (TCBP)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$0.379

Offen:

$0.3749

24-Stunden-Volumen:

402.15K

Relative Volume:

0.18

Marktkapitalisierung:

$3.76M

Einnahmen:

$4.60M

Nettoeinkommen (Verlust:

$-6.25M

KGV:

-0.00518

EPS:

-70.6412

Netto-Cashflow:

$-15.38M

1W Leistung:

-20.38%

1M Leistung:

-30.66%

6M Leistung:

-94.64%

1J Leistung:

-98.04%

1-Tages-Spanne:

$0.3501

$0.3756

1-Wochen-Bereich:

$0.3501

$0.45

52-Wochen-Spanne:

$0.3487

$26.16

Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile

Firmenname

Tc Biopharm Holdings Plc Adr

Sektor

Healthcare (1176)

Branche

Biotechnology (685)

Telefon

01414337557

Adresse

MAXIM 1, HOLYTOWN

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TCBP's Discussions on Twitter

Vergleichen Sie TCBP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TCBP Tc Biopharm Holdings Plc Adr	0.3661	3.76M	4.60M	-6.25M	-15.38M	-70.64
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Tc Biopharm Holdings Plc Adr Aktie (TCBP) Neueste Nachrichten

Jan 08, 2025

TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance - TipRanks

Jan 08, 2025

Dec 31, 2024

TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt - TipRanks

Dec 31, 2024

TC BioPharm advances in acquisition strategy - Investing.com India

Dec 31, 2024

Dec 30, 2024

What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register

Dec 30, 2024

TC BioPharm Approves Key Resolutions to Enhance Strategic Flexibility - TipRanks

Dec 30, 2024

No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register

Dec 30, 2024

NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register

Dec 30, 2024

If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register

Dec 30, 2024

Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register

Dec 30, 2024

Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register

Dec 30, 2024

Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register

Dec 30, 2024

Dec 17, 2024

TC BioPharm Advances Strategic Financial Initiative with New ADS Offering - TipRanks

Dec 17, 2024

Dec 16, 2024

TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa

Oct 30, 2024

TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India

Oct 30, 2024

Oct 25, 2024

TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks

Oct 25, 2024

TC BioPharm denies Nasdaq delisting rumors - Investing.com

Oct 25, 2024

Oct 22, 2024

TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks

Oct 22, 2024

United States shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com India

Oct 22, 2024

Oct 21, 2024

TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks

Oct 21, 2024

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com

Oct 21, 2024

Oct 08, 2024

TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Oct 08, 2024

Oct 05, 2024

TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks

Oct 05, 2024

Sep 25, 2024

TCBP Announces Site Opening of Guys and St. Thomas Hospital - StockTitan

Sep 25, 2024

Sep 12, 2024

TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks

Sep 12, 2024

Sep 09, 2024

TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India

Sep 09, 2024

TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks

Sep 09, 2024

Sep 06, 2024

TC BioPharm to begin monkeypox treatment studies - Investing.com

Sep 06, 2024

Sep 04, 2024

TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle

Sep 04, 2024